Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery-Reference-Cited by-同舟云学术

Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery

Published:2009-01 Issue:1 Volume:31 Page:194-212
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Wolowacz Sorrel E.,Roskell Neil S.,Maciver Fiona,Beard Stephen M.,Robinson Paul A.,Plumb Jonathan M.,Dolan Gerry,Brenkel Ivan J.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference59 articles.

1. for the RIETE Investigators Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry;Arcelus;Thromb Haemost,2008

2. Long-term outcomes after deep venous thrombosis of the lower extremities;Prandoni;Vasc Med,1998

3. Antithrombotic therapy practices in US hospitals in an era of practice guidelines;Tapson;Arch Intern Med,2005

4. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition);Geerts;Chest,2008

5. Reduction of out-of-hospital symptomatic venous thromboembolism by extended thromboprophylaxis with low-molecular-weight heparin following elective hip arthroplasty: A systematic review;O’Donnell;Arch Intern Med,2003

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thromboprophylaxis of Patients Submitted to Total Hip and Knee Arthroplasty: A Cost-Effectiveness Assessment From the Perspective of the Brazilian National Health System;Value in Health Regional Issues;2022-09

2. Incremental net monetary benefit of direct oral anticoagulants for the prevention of venous thromboembolism after total knee or hip replacement: A systematic review and meta-analysis;Thrombosis Research;2022-08

3. Recommendations from the ICM-VTE: General;Journal of Bone and Joint Surgery;2022-03-16

4. Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis;Thrombosis Journal;2021-09-29

5. Economic Evaluation of New Oral Anticoagulants in Prevention of Venous Thrombosis Following Joint Replacement Surgery: A Systematic Review;Clinical Therapeutics;2021-05